IMC Chicago
LEGN icon

IMC Chicago’s Legend Biotech LEGN Stock Holding History

IMC Chicago’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$279K Buy
15,400
+2,500
+19% +$47.7K ﹤0.01% 4682
2025
Q4 		$280K Sell
12,900
-6,700
-34% -$192K ﹤0.01% 3840
2025
Q3 		$639K Buy
+19,600
New +$724K ﹤0.01% 3015

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

IMC Chicago's LEGN Position: Q1 2026 in Review

IMC Chicago reduced its Legend Biotech (LEGN) stake by 22% in Q1 2026, selling an estimated $96.3K and leaving 17,894 shares worth $324K. The position accounts for ﹤0.01% of the portfolio, ranked #4508.

IMC Chicago first reported a position in LEGN in Q4 2025 and has held it in 2 quarters since. The position peaked at $499K in Q4 2025. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • IMC Chicago held 17,894 shares of Legend Biotech worth $324K as of Q1 2026.
  • IMC Chicago sold 5,051 Legend Biotech shares in Q1 2026, an estimated $96.3K.
  • Legend Biotech made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #4508 holding.
  • IMC Chicago first reported a position in Legend Biotech in Q4 2025 and has held it in 2 quarters since.
  • IMC Chicago's Legend Biotech position peaked at $499K in Q4 2025.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.